Femasys stock.

Femasys GAAP EPS of -$0.22 misses by $0.02, revenue of $0.32M misses by $0.05M SA News Thu, Aug. 10 Femsys stock jumps 21% after FDA green lights FemBloc testingNov 28, 2023 · What is the target price for Femasys (FEMY) stock? The latest price target for Femasys ( NASDAQ: FEMY) was reported by HC Wainwright & Co. on Tuesday, November 14, 2023. The analyst firm set a ... Dec 1, 2023 · Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools. Identify stocks that meet your criteria using seven unique stock screeners. Femasys Inc. FEMY shares are trading lower Tuesday. The stock has been volatile since the company received FDA 510(k) clearance for FemaSeed, an infertility treatment, towards the end of September .

In a concurrent private placement, Femasys has also agreed to issue and sell unregistered warrants to purchase up to an aggregate of 3,196,722 shares of common stock. The offering is expected to close on or about April 20, 2023, subject to the satisfaction of customary closing conditions.Shares Outstanding 21.65 M Public Float 19.48 M Yield FEMY is not currently paying a regular dividend. Latest Dividend N/A Ex-Dividend Date N/A Short Interest (10/31/23) …WebNov. 30, 2023 5:40 PM ET Femasys Inc. (FEMY) By: Tiyashi Datta, SA News Editor. Femasys ( NASDAQ: FEMY) filed a prospectus related to the offer and resale by the selling stockholders of up to an ...

See the latest Femasys Inc stock price (FEMY:XNAS), related news, valuation, dividends and more to help you make your investing decisions.

MarketWatch IBD DJIA 35336.10 0.15% S&P 500 4553.34 0.13% U.S. 10 Yr 3/32 Yield 4.434% Euro 1.0937 0.10% Subscribe Sign In Femasys Inc. FEMY (U.S.: Nasdaq) Overview News Femasys Inc. No...May 26, 2023 · At Femasys Inc., we promise to treat your data with respect and will not share your information with any third party. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below. If you experience any issues with this process, please contact us for further assistance. Gainers Femasys Inc. (NASDAQ: FEMY) shares rose 201% to $1.00 in pre-market trading after the company received FDA 510(k) clearance for FemaSeed, an infertility treatment.Nov 17, 2023 · Femasys stock has received a consensus rating of buy. The average rating score is and is based on 12 buy ratings, 0 hold ratings, and 0 sell ratings. What was the 52-week low for Femasys stock?

Femasys Inc. FEMY shares are trading lower Tuesday. The stock has been volatile since the company received FDA 510(k) clearance for FemaSeed, an infertility treatment, towards the end of September .

Femasys Inc. Announces the Appointment of James Liu, M.D., as Chief Medical OfficerWeb

If you want to keep up to date on the stock market you have a device in your pocket that makes that possible. Your phone can track everything finance-related and help keep you up to date on the world markets.Femasys expects the resulting patent, when issued, will have an anticipated expiration in 2039, at the earliest. In October, Femasys regained compliance with Nasdaq’s minimum bid price requirement, after having received a notice on June 1, 2023 from Nasdaq that they were not in compliance with such requirement.John Dyett has not been actively trading shares of Femasys over the course of the past ninety days. Most recently, on Wednesday, June 23rd, John Dyett bought 53,500 shares of Femasys stock. The stock was acquired at an average cost of $12.93 per share, with a total value of $691,755.00. Learn More on John Dyett's trading history.Femasys : FEMY got FDA ... This revolutionary clearance has primed ICU for an explosion, and accordingly, analysts label the stock as a Buy with an average target price of $1.00. That represents a ...Stock Price Targets. High, $12.00. Median, $8.50. Low, $5.00. Average, $8.50. Current Price, $0.9522. Yearly Numbers. Estimates. FEMY will report 2023 earnings ...Real stock prices are not the same as the last traded stock price. Real stock prices are adjustments to closing stock prices. The adjustments are used in a variety of ways, including dividends, the range of prices and the closing price of t...ATLANTA, Nov. 30, 2023 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a biomedical company focused on meeting significant unmet needs for women worldwide with a broad portfolio of in-office, accessible solutions, including a lead, late-clinical stage product candidate and innovative therapeutic and diagnostic products, today announced the ...

What is Femasys's consensus rating and price target? According to the issued ratings of 3 analysts in the last year, the consensus rating for Femasys stock is Buy based on the current 3 buy ratings for FEMY. The average twelve-month price prediction for Femasys is $9.00 with a high price target of $10.00 and a low price target of $7.00.Oct 2, 2023 · Femasys Inc, a medical technology company, has been attracting attention from investors due to its positive stock performance on October 2, 2023. According to data from CNN Money, the company has received favorable price forecasts from four analysts, with a median target of $8.50. The high estimate is $13.00, while the low estimate is $5.00. About Femasys. Femasys is a biomedical company focused on meeting significant unmet needs for women worldwide with a broad portfolio of in-office, accessible solutions, including a lead ...Historical Stock Quote. Investment Calculator. Amount ($) Start Date: End Date: Compare to: S&P 500. Nasdaq 100. Dow 30. Other. Reinvest Dividends. Calculate Investment. ... At Femasys Inc., we promise to treat your data with respect and will not share your information with any third party.Overview. Femasys Inc. is a biomedical company aiming to meet women's needs worldwide by developing a suite of product candidates that include minimally invasive, in-office technologies for reproductive health.Comparatively, 16.4% of Femasys shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term. Earnings & Valuation. This table compares Beyond Air and Femasys’ revenue, earnings per share …

Femasys Inc. (FEMY) delivered earnings and revenue surprises of -8.70% and 13.25%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life. Back. Femasys Inc. (FEMY) Add to watchlist. NasdaqCM - NasdaqCM Real Time Price. Currency in USD. 1.0300 +0.1162 (+12.72%) At close: …With 11.8mil shares outstanding and a share price of $7.5, the market cap of Femasys is $88.5mil and with a cash position of $33mil, the enterprise value of the company is expected to be $55.5mil ...Nov 29, 2023 · Femasys GAAP EPS of -$0.22 misses by $0.02, revenue of $0.32M misses by $0.05M SA News Thu, Aug. 10 Femsys stock jumps 21% after FDA green lights FemBloc testing Nov 27, 2023 · What is Femasys's consensus rating and price target? According to the issued ratings of 3 analysts in the last year, the consensus rating for Femasys stock is Buy based on the current 3 buy ratings for FEMY. The average twelve-month price prediction for Femasys is $9.00 with a high price target of $10.00 and a low price target of $7.00. Femasys : Corporate Presentation June 2023. Disrupting Convention in Women's Health Through Continuous Innovation. This Presentation contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 relating to our business, operations and financial conditions, including but not limited to current ...Femasys Inc. (NASDAQ: FEMY) shares were stationery Thursday, as the biomedical company focused on meeting significant unmet needs for women worldwide with a broad portfolio of products, announced ...At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life. Back. Femasys Inc. (FEMY) Add to watchlist. NasdaqCM - NasdaqCM Real Time Price. Currency in USD. 1.0300 +0.1162 (+12.72%) At close: …Sep 29, 2023 · Femasys Inc. (NASDAQ: FEMY) shares are trading higher Friday after HC Wainwright maintained a Buy rating on the stock and raised its price target from $5 to $13. 146.71. +1.95%. 45.70M. View today's Femasys Inc stock price and latest FEMY news and analysis. Create real-time notifications to follow any changes in the live stock price.

PharmaCyte Biotech, Inc. (Nasdaq: PMCB) (PharmaCyte or the Company) announces it has made a $5 million investment in Femasys, Inc. (Nasdaq:FEMY) (Femasys), a biomedical company focused on meeting... Femasys Inc. Announces Financial Results for the Third Quarter Ended September 30, 2023 and Provides Corporate Update Globe Newswire • …

Femasys Stock Earnings. The value each FEMY share was expected to gain vs. the value that each FEMY share actually gained. Femasys ( FEMY) reported Q3 2023 earnings per share (EPS) of -$0.26, missing estimates of -$0.22 by 21.75%. In the same quarter last year, Femasys 's earnings per share (EPS) was -$0.25. Femasys is expected to release next ...

Femasys (FEMY) stock price is up 1,250% but there are 2 key risks. The remarkable Femasys (NASDAQ: FEMY) stock price comeback continued on Monday as demand for the shares continued. The shares surged by more than 45% on Friday and gained by another 15% in the pre-mar... 7 weeks ago - Invezz.Femasys Inc. FEMYNASDAQ FEMYNASDAQ 0.9138USD +0.0118 +1.31% At close at 16:59 UTC-8 See on Supercharts Overview News Ideas Financials Technicals Forecast …WebSEC Filings. Select Year: Filter filing type: Date Filing Type Filing Description Download / View. 11/30/2023. S-3. Securities Registration Statement (simplified form) 11/29/2023. 8-K. Current report filing.FEMY Stock 12 Months Forecast. Based on 4 Wall Street analysts offering 12 month price targets for Femasys in the last 3 months. The average price target is $10.67 with a high forecast of $13.00 and a low forecast of $7.00. The average price target represents a 620.95% change from the last price of $1.48.ATLANTA, Nov. 30, 2023 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a biomedical company focused on meeting significant unmet needs for women worldwide with a broad portfolio of in-office, accessible solutions, including a lead, late-clinical stage product candidate and innovative therapeutic and diagnostic products, today announced the ...Stock analysis for Femasys Inc (FEMY:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile.ATLANTA, May 11, 2023 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a biomedical company aiming to meet women's needs worldwide by developing a suite of product candidates that include ...Femasys has a market capitalisation of US$22m and burnt through US$11m last year, ... It does not constitute a recommendation to buy or sell any stock, ...The stock is up ~205% in after-hours trading on Monday. Femasys (FEMY) says that FeedSeed is "less invasive and more affordable than assisted reproduction procedures, such as in vitro ...Sep 25, 2023 · Femasys has received 510 (k) Clearance from the FDA for FemaSeed®, an innovative infertility treatment. The clearance allows for the U.S. commercialization of FemaSeed®, which delivers sperm directly to the fallopian tube. FemaSeed® is expected to reduce procedural complications compared to other treatments.

An Atlanta woman-founded, women's healthcare company plans to raise $40 million in an initial public stock offering. Suwanee-based Femasys Inc. says in plans filed May 14 with the Securities and ...Stock Info Stock Quote Price $1.03 Volume 3,368,658 Change +0.12 % Change +12.72% Today's Open $0.96 Previous Close $0.91 Intraday High $1.14 Intraday …WebFemasys expects the resulting patent, when issued, will have an anticipated expiration in 2039, at the earliest. In October, Femasys regained compliance with Nasdaq’s minimum bid price requirement, after having received a notice on June 1, 2023 from Nasdaq that they were not in compliance with such requirement.About Femasys. Femasys is a biomedical company focused on meeting significant unmet needs for women worldwide with a broad portfolio of in-office, accessible solutions, including a lead ...Instagram:https://instagram. nasdaq trvghow to trade in forexhow do financial planners get paidonline car buying stocks Femasys was previously notified by Nasdaq on June 1, 2023 that it was not in compliance with the minimum bid price rule (“the Rule”) because its common stock failed to meet the closing bid ...ATLANTA, May 11, 2023 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a biomedical company aiming to meet women's needs worldwide by developing a suite of product candidates that include ... low cost futures brokersmanage crypto portfolio Gainers telesis bio (nasdaq:tbio) shares increased by 32.5% to $0.53 during wednesday's after-market session. Femasys shares rose 19.28% and axcella health shares rose 13.1%. Gyre therapeutics stock decreased by 8.67% and impel pharmaceuticals declined by 13.3%.The stock is up ~205% in after-hours trading on Monday. Femasys (FEMY) says that FeedSeed is "less invasive and more affordable than assisted reproduction procedures, such as in vitro ... health insurance company in new jersey The past week has seen Femasys Inc. (FEMY), a company known for its work in the healthcare sector, experience fluctuations in its stock price. With a 52-week range of $0.2480 - $4.7500 and an average volume of 14,323,125, the stock's performance has been intriguing. Photo by Afif Ramdhasuma on Unsplash. Factors driving this week's …H.C. Wainwright analyst Emily Bodnar maintained a Buy rating on Femasys (FEMY – Research Report) today and set a price target of $5.00.The company’s shares opened today at $0.82. According to ...